Silver Book Fact

Lifetime risk of developing hypertension is estimated at 90% for people with normal blood pressures at age 55 or 65 and who live to age 80 to 85, respectively.

Cutler, David M., Genia Long, Ernst R. Berndt, Jimmy Royer, Andree-Anne Fournier, Alicia Sasser, and Pierre Cremieux. The Value Of Antihypertensive Drugs: A perspective on medical innovation. Health Affairs. 2007; 26(1): 97-110

Reference

Title
The Value Of Antihypertensive Drugs: A perspective on medical innovation
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2007
Authors
Cutler, David M., Genia Long, Ernst R. Berndt, Jimmy Royer, Andree-Anne Fournier, Alicia Sasser, and Pierre Cremieux
Volume & Issue
Volume 26, Issue 1
Pages
97-110

Categories

  • Cost of Disease
  • Human Burden

Related Facts

  • In the U.S., the estimated direct and indirect cost of cardiovascular disease for 2009 is $475.3 billion.  
  • AFib, an economic burden
    AFib is a major economic burden for the U.S. with at least $6.65 billion in healthcare costs attributable to the disease each year. This estimate may be low. One study…  
  • It is estimated that an additional 175,000 silent first myocardial infarctions occur each year.  
  • Prevalence of stroke by age and sex  
  • Healthcare costs of atrial fibrillation
    Atrial fibrillation (AF) is a major economic burden for society with the biggest cost driver being hospitalizations—accounting for 52% of costs. Drugs for AF account for 23% of costs, consultations…